WallStSmart
PSNL

Personalis Inc

NASDAQ: PSNL · HEALTHCARE · DIAGNOSTICS & RESEARCH

$5.04
-8.36% today

Updated 2026-04-29

Market cap
$575.73M
P/E ratio
P/S ratio
8.27x
EPS (TTM)
$-0.91
Dividend yield
52W range
$4 – $12
Volume
1.6M

Personalis Inc (PSNL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$9.39M$37.77M$65.21M$78.65M$85.49M$65.05M$73.48M$84.61M$69.65M
Revenue growth (YoY)+302.2%+72.6%+20.6%+8.7%-23.9%+13.0%+15.2%-17.7%
Cost of revenue$11.74M$25.97M$43.13M$58.53M$53.84M$51.70M$55.27M$57.79M$53.87M
Gross profit$-2.34M$11.80M$22.08M$20.11M$31.66M$13.35M$18.21M$26.82M$-53.87M
Gross margin-24.9%31.3%33.9%25.6%37.0%20.5%24.8%31.7%-77.3%
R&D$9.92M$14.30M$22.42M$28.57M$49.31M$64.91M$64.78M$48.91M$50.26M
SG&A$9.90M$11.27M$22.08M$33.69M$47.70M$63.97M$49.73M$46.19M$53.57M
Operating income$-22.16M$-13.77M$-22.42M$-42.15M$-65.35M$-115.53M$-109.94M$-68.27M$-88.06M
Operating margin-236.0%-36.5%-34.4%-53.6%-76.4%-177.6%-149.6%-80.7%-126.4%
EBITDA$-21.07M$-14.92M$-19.19M$-35.46M$-59.01M$-104.64M$-96.81M$-70.30M$-71.00M
EBITDA margin-224.4%-39.5%-29.4%-45.1%-69.0%-160.9%-131.7%-83.1%-101.9%
EBIT$-22.29M$-17.98M$-23.94M$-41.22M$-65.03M$-113.07M$-108.10M$-81.24M$-81.04M
Interest expense$1.30M$1.89M$1.13M$2000.00$184000.00$201000.00$110000.00$24000.00$205000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-23.60M$-19.89M$-25.08M$-41.28M$-65.23M$-113.31M$-108.30M$-81.28M$-81.27M
Net income growth (YoY)+15.7%-26.1%-64.6%-58.0%-73.7%+4.4%+24.9%+0.0%
Profit margin-251.2%-52.6%-38.5%-52.5%-76.3%-174.2%-147.4%-96.1%-116.7%